Pharma

Pharma

National Lipid Day a timely reminder of dyslipidemia, says GlobalData

National Lipid Day, observed on 10 May every year creates awareness of dyslipidaemia, says GlobalData, a leading data and analytics company. Dr Shireen Mohammad, Cardiovascular & Metabolic Disorders Analyst at GlobalData, comments: “An unmet need in the dyslipidemia space is patient education and National Lipid Day is a great way to raise awareness for this […]

Pharma

GlobalData forecasts Immunogen’s Elahere sales to reach $615 million by 2029

US-based Immunogen recently announced positive top-line data from their Phase III MIRASOL trial evaluating Elahere (mirvetuximab) for the treatment of platinum-resistant ovarian cancer. The company plans to use the data to support their forthcoming supplemental Biologics Licensing Application for full FDA approval. Elahere’s sales are expected to reach $615 million by 2029, registering a 114% […]

Pharma

Bristol Myers Squibb’s Sotyktu for psoriasis to see $2.9bn in sales by 2029, forecasts GlobalData

Bristol Myers Squibb (BMS) recently announced the European Commission approval for Sotyktu (deucravacitinib), its first-in-class, selective, allosteric tyrosine kinase 2 (TYK2) inhibitor for adults with moderate-to-severe plaque psoriasis (PsO). Representing a new class of small molecules with a unique mechanism of action, Sotyktu is set to become a blockbuster for the treatment of PsO with […]

Pharma

FDA accelerated approval of Biogen Qalsody game changer for rare subgroup of ALS patients, says GlobalData

The US Food and Drug Administration (FDA) has recently granted accelerated approval for Biogen’s Qalsody (tofersen), a drug that targets a specific group of amyotrophic lateral sclerosis (ALS) patients who have a superoxide dismutase 1 (SOD1) gene mutation. This decision is considered a game changer for this rare subgroup of ALS patients and sets a […]

Pharma

Brexit and COVID-19 caused greatest negative impact on UK healthcare sector, finds GlobalData

While some believed that leaving the EU would bring opportunities for the UK and its life sciences sector, three years on since the UK departed from the EU, Brexit and COVID-19 were highlighted as the events having the most negative impact on the UK healthcare sector, in a survey conducted by GlobalData, a leading data […]

Pharma

GlobalData forecasts oncology drug sales to generate $2.2 trillion between 2023 and 2029

In the race to combat cancer, the field of oncology has experienced strong growth in recent years. With forecasts pointing towards a continued upward trend, it is no surprise that the oncology market has emerged as the largest therapy area by sales, poised to generate $2.2 trillion in sales between 2023 and 2029. This significant […]

Pharma

Lack of innovation means checkpoint inhibitor trials continue to focus primarily on PD-1/L1, says GlobalData

Over 95% of the ongoing Phase III trials in the US featuring an immune checkpoint modulator involve either a PD-1 or PD-L1-targeting drug. Given the proven efficacy of these targets this is not necessarily surprising. However, for patients unable to tolerate, or refractory to these drugs, this lack of innovation is disappointing, says GlobalData, a […]

Pharma

GlobalData stresses need for patient education with injectable levodopa infusions for Parkinson’s disease treatment

Safety data on AbbVie’s ABBV-951 (foslevodopa/foscarbidopa) and NeuroDerm’s ND0612 (levodopa/carbidopa) for the treatment of Parkinson’s disease (PD) were showcased at the American Academy of Neurology (AAN) 2023 Annual Meeting. Should they receive FDA approval, these innovative levodopa delivery systems could offer an improved route of administration and will create additional options to control various motor […]

Pharma

Astellas acquisition of Iveric Bio to boost ophthalmology portfolio, expected to achieve leadership position in geographic atrophy, says GlobalData

Following the news that Japan-based Astellas Pharma entered into a definitive agreement to acquire US-based biopharmaceutical company Iveric Bio for $5.9 billion to create a world class ophthalmology entity; Prashant Khadayate, Pharma Analyst at GlobalData, a leading data and analytics company, offers his view: “Astellas mentions blindness and regeneration as one of the five focus […]

Pharma

Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis, finds GlobalData

UK healthcare professionals (HCPs) believe that Brexit had exacerbated the National Health Service (NHS) staffing crisis, according to a survey by GlobalData, a leading data and analytics company. In a GlobalData’s survey* titled “Brexit and the Healthcare Industry”, a total of 92% of surveyed physicians believed that Brexit had a negative impact on NHS staff […]

Pharma

Healthcare industry professionals feel more negative towards Brexit, finds GlobalData survey

More than half of the surveyed healthcare industry professionals indicated that their sentiment on the impact of Brexit on the UK’s healthcare sector became more negative, according to a survey* by GlobalData. The leading data and analytics company notes that 54% of healthcare industry professionals in the survey believed that their sentiment worsened three years […]

Pharma

Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData

German drugmaker Bayer recently announced that it will shift the focus of its drug research away from women’s health to four core therapeutic areas: oncology, cardiovascular, neurology, and rare diseases/immunology. In the women’s health space, the company has a presence with its Yasmin brand of birth-control pills and the intrauterine device Mirena. The news of […]

Pharma

As Cytokinetics ALS drug fails Phase III trial, attention turns to cardiomyopathy candidate aficamten, says GlobalData

Cytokinetics, a San Francisco-based biotechnology company, is set to wind down the Phase III trial of its amyotrophic lateral sclerosis (ALS) pipeline drug, reldesemtiv, as there is no evidence of an effect compared to placebo on primary or secondary endpoints. This comes after the pharma company announced the FDA had rejected its heart failure drug, […]

Pharma

GlobalData identifies significant unmet needs in obesity therapeutics market

Obesity is a major public health concern with a significant impact on morbidity, mortality, and healthcare costs worldwide. The obesity therapeutics market is expected to grow as the prevalence of obesity increases, but it is also facing considerable unmet needs. Despite the anticipated arrival of novel therapies in the next decade, major opportunities remain for […]

Pharma

Cipla continues to strengthen anti-diabetes innovative portfolio through partnerships with MNCs in India, says GlobalData

Cipla holds a prominent position in the top five therapy areas in India, except for the anti-diabetes and gastrointestinal segment. Against this backdrop, the Indian pharma major is constantly partnering with multinational companies to get access to an innovative portfolio with a focus on diabetes, says GlobalData, a leading data and analytics company. Cardiology, anti-diabetes, […]

Pharma

Arrowhead Pharmaceuticals targets unmet needs in rare lipid disorders, says GlobalData

Familial chylomicronemia syndrome (FCS) is a rare autosomal recessive disorder caused by a mutation in lipoprotein lipase. FCS is characterized by the body’s inability to break down fats in the blood, which leads to the accumulation of chylomicrons. This can cause severe health complications such as pancreatitis and cardiovascular disease. One potential approach is the […]

Pharma

Antimicrobial resistance takes centre stage at ECCMID 2023, says GlobalData

Navigating the ever-increasing challenges of antimicrobial resistance (AMR), which occurs when bacteria, viruses, fungi, or parasites no longer respond to antimicrobial treatment, has been a key theme at the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) 2023 conference, says GlobalData, a leading data and analytics company. Stephanie Kurdach, Infectious Disease Analyst at GlobalData, […]

Pharma

FDA rejection to dent mirikizumab’s chances to become first-to-market IL-23 inhibitor therapy for ulcerative colitis in US, says GlobalData

The FDA recently rejected Eli Lilly’s biologic license application (BLA) for their anti-interleukin (IL) -23, mirikizumab, which is in development for the treatment of ulcerative colitis (UC). This news will likely delay mirikizumab’s entry into the US market as it will inevitably fall behind competitors, which are aiming to enter the UC market during 2021-31, […]

Pharma

World Malaria Day 2023: Huge milestones made towards Zero Malaria goal, says GlobalData

World Malaria Day is commemorated on 25 April every year to recognize the global efforts to increase public awareness and eradicate malaria. This year’s theme is “Time to Deliver Zero Malaria: Invest, Innovate, Implement.” Significant strides have been made towards this goal in recent years due to the emergence of the first prophylactic vaccines for […]

Pharma

Novel pipeline therapies to drive ulcerative colitis market across 8MM to $9.6 billion by 2031, forecasts GlobalData

The ulcerative colitis (UC) market across the eight major markets (8MM*) is forecast to grow at a compound annual growth rate (CAGR) of 2.8% from $7.2 billion in 2021 to $9.6 billion in 2031, driven by the potential introduction of 11 promising late-stage pipeline products and an increase in the prevalent patient population, according to […]

Prev 1 … 36 37 38 39 40 … 110 Next

National Lipid Day a timely reminder of dyslipidemia, says GlobalData

GlobalData forecasts Immunogen’s Elahere sales to reach $615 million by 2029

Bristol Myers Squibb’s Sotyktu for psoriasis to see $2.9bn in sales by 2029, forecasts GlobalData

FDA accelerated approval of Biogen Qalsody game changer for rare subgroup of ALS patients, says GlobalData

Brexit and COVID-19 caused greatest negative impact on UK healthcare sector, finds GlobalData

GlobalData forecasts oncology drug sales to generate $2.2 trillion between 2023 and 2029

Lack of innovation means checkpoint inhibitor trials continue to focus primarily on PD-1/L1, says GlobalData

GlobalData stresses need for patient education with injectable levodopa infusions for Parkinson’s disease treatment

Astellas acquisition of Iveric Bio to boost ophthalmology portfolio, expected to achieve leadership position in geographic atrophy, says GlobalData

Majority of UK physicians believe Brexit aggravated NHS staff shortage crisis, finds GlobalData

Healthcare industry professionals feel more negative towards Brexit, finds GlobalData survey

Yasmin and Mirena to take back seat from Bayer’s future drug strategy, says GlobalData

As Cytokinetics ALS drug fails Phase III trial, attention turns to cardiomyopathy candidate aficamten, says GlobalData

GlobalData identifies significant unmet needs in obesity therapeutics market

Cipla continues to strengthen anti-diabetes innovative portfolio through partnerships with MNCs in India, says GlobalData

Arrowhead Pharmaceuticals targets unmet needs in rare lipid disorders, says GlobalData

Antimicrobial resistance takes centre stage at ECCMID 2023, says GlobalData

FDA rejection to dent mirikizumab’s chances to become first-to-market IL-23 inhibitor therapy for ulcerative colitis in US, says GlobalData

World Malaria Day 2023: Huge milestones made towards Zero Malaria goal, says GlobalData

Novel pipeline therapies to drive ulcerative colitis market across 8MM to $9.6 billion by 2031, forecasts GlobalData

Browse

Company information